We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Single-Cell Advances in Functional Immune Monitoring for Developing Immune Therapies and Uncovering Disease Pathogenesis

Download this roundtable to learn new strategies for using single-cell functional proteomics to treat some of the world’s most devastating diseases.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Recent advancements and current strategies for developing immune-based therapies.
How single-cell functional proteomics reveal insights into the development of better therapies.
How single-cell functional proteomics shed light on the drivers of disease progression.
How to overcome challenges at the different stages of immune therapy development.
How understanding the function of different cell types help accelerate the development of novel therapies.
A Deeper Look

More about this

An Expert Roundtable with Abhishek D. Garg, PhD, Luca Gattinoni, MD, and Peggy Sotiropoulou, PhD

GEN spoke to three thought leaders working on immune therapies to hear their views and strategies on using single-cell functional proteomics in their quest to treat some of the world’s most devastating diseases.

Download this expert panel discussion to learn more!

Get the